Abstract
Background: Data regarding the possible effects of estrogen on ghrelin secretion in humans are limited and contradictory. Aim: To investigate the effect of estradiol (E2) on ghrelin levels in normal pre- and post-menopausal women. Subjects and methods: A total of 21 women divided into 3 groups, i.e.13 normally cycling women (no.=7, group 1 and no.=6, group 2) and 8 post-menopausal women (group 3). Women of group 1 received increasing doses of E2 through skin patches from cycle days 3 to 5. Women of group 2, underwent total abdominal hysterectomy plus bilateral salpingooophorectomy (TAH+BSO) on cycle day 3. Women of group 3 received po increasing doses of E2 valerate for 15 days. Acylated ghrelin and E2 were measured in all blood samples. Results: In group 1, plasma ghrelin levels did not show any significant changes for the week following cycle day 3. In group 2, ghrelin levels were similar before and after TAH+BSO and remained stable during the first 7 post-operative days. In group 3, no significant changes in plasma ghrelin levels were seen during the 15 days of E2 administration. Conclusions: The present study demonstrates for the first time that ghrelin values were not affected either by exogenous short-term estrogen administration to pre- and post-menopausal women or following ovariectomy in pre-menopausal women. It is suggested that ovarian hormones are not involved in the regulation of ghrelin secretion in women.
Similar content being viewed by others
References
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from the stomach. Nature 1999, 402: 656–60.
Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001, 86: 4753–8.
Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000, 407: 908–13.
Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141: 4325–8.
van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25: 426–57.
Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, Muccioli G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) 2005; 62: 1–17.
Dafopoulos K, Sourlas D, Kallitsaris A, Pournaras S, Messinis IE. Blood ghrelin, resistin and adiponectin concentrations during the normal menstrual cycle. Fertil Steril 2009, 92: 1389–94.
Clegg DJ, Brown LM, Zigman JM, et al. Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats. Diabetes 2007, 56: 1051–8.
Matsubara M, Sakata I, Wada R, Yamazaki M, Inoue K, Sakai T. Estrogen modulates ghrelin expression in the female rat stomach. Peptides 2004, 25: 289–97.
Shibata K, Hosoda H, Kojima M, et al. Regulation of ghrelin secretion during pregnancy and lactation in the rat: possible involvement of the hypothalamus. Peptides 2004, 25: 279–87.
Gualillo O, Caminos JE, Kojima M, et al. Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur J Endocrinol 2001, 144: 687–90.
Makino Y, Hosoda H, Shibata K, et al. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 2002, 39: 781–4.
Lebenthal Y, Gat-Yablonski G, Shtaif B, Padoa A, Phillip M, Lazar L. Effect of sex hormone administration on circulating ghrelin levels in peripubertal children. J Clin Endocrinol Metab 2006, 91: 328–31.
Grinspoon S, Miller KK, Herzog DB, Grieco KA, Klibanski A. Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. J Clin Endocrinol Metab 2004, 89: 3988–93.
Kellokoski E, Pöykkö SM, Karjalainen AH, et al. Estrogen replacement therapy increases plasma ghrelin levels. J Clin Endocrinol Metab 2005, 90: 2954–63.
Messinis IE, Papageorgiou I, Milingos S, Asprodini E, Kollios G, Seferiadis K. Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women. Hum Reprod 2001, 16: 1827–32.
Dafopoulos K, Mademtzis I, Vanakara P, et al. Evidence that termination of the estradiol-induced LH surge in women is regulated by ovarian factors. J Clin Endocrinol Metab 2006, 91: 641–5.
Dafopoulos K, Kotsovassilis CG, Milingos S, et al. Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role. Hum Reprod 2004, 19: 1985–92.
Sagsöz N, Orbak Z, Noyan V, Yücel A, Uçar B, Yıldız L. The effects of oral contraceptives including low-dose estrogen and drospiren-one on the concentration of leptin and ghrelin in polycystic ovary syndrome. Fertil Steril 2009, 92: 660–6.
De Souza MJ, Leidy HJ, O’Donnell E, Lasley B, Williams NI. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004, 89: 3536–42.
Di Carlo C, Tommaselli GA, Gargano V, et al. Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women. Menopause 2007, 14: 38–44.
Chu MC, Cosper P, Nakhuda GS, Lobo RA. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil Steril 2006, 86: 1669–75.
Villa P, Costantini B, Perri C, Suriano R, Ricciardi L, Lanzone A. Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women. Fertil Steril 2008, 89: 398–403.
Lambrinoudaki IV, Christodoulakos GE, Economou EV, et al. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Maturitas 2008, 59: 62–71.
Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50: 707–9.
Chu M, Cosper P, Orio F, Carmina E, Lobo R. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am J Obstet Gynecol 2006, 194: 100–4.
Purnell JQ, Weigle DS, Breen P, Cummings DE. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 2003, 88: 5747–52.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dafopoulos, K., Chalvatzas, N., Kosmas, G. et al. The effect of estrogens on plasma ghrelin concentrations in women. J Endocrinol Invest 33, 109–112 (2010). https://doi.org/10.1007/BF03346563
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346563